Results 311 to 320 of about 20,489,060 (330)

Is testosterone a substrate of P-gp?

Experimental and Clinical Endocrinology & Diabetes, 2004
M Ebinger, M Uhr
openaire   +1 more source

Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer.

European journal of medicinal chemistry, 2017
Prashant Joshi, R. Vishwakarma, S. Bharate   +2 more
semanticscholar   +1 more source

Metformin enhances doxorubicin sensitivity via inhibition of doxorubicin efflux in P‐gp‐overexpressing MCF‐7 cells

Chemical Biology and Drug Design, 2018
Vahid Shafiei‐Irannejad, N. Samadi, B. Yousefi, R. Salehi, Kobra Velaei, N. Zarghami   +5 more
semanticscholar   +1 more source

A Drug-Drug Interaction Study of Vadadustat Coadministered With Cyclosporine, a P-gp Inhibitor, and Digoxin, a P-gp Substrate

Advances in Chronic Kidney Disease, 2021
openaire   +1 more source

MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017
Chaojing Lu, Zhengxiang Shan, Chunguang Li, Lixin Yang   +3 more
semanticscholar   +1 more source

Delivery of siRNA silencing P-gp in peptide-functionalized nanoparticles causes efflux modulation at the blood-brain barrier.

Nanomedicine, 2017
Maria João Gomes, P. Kennedy, S. Martins, B. Sarmento   +3 more
semanticscholar   +1 more source

P-gp expression and function in T-lymphocytes

Clinical and Applied Immunology Reviews, 2003
Albert D. Donnenberg, Vera S. Donnenberg
openaire   +1 more source

Quantitative Assessment of the Impact of Fluorine Substitution on P-Glycoprotein (P-gp) Mediated Efflux, Permeability, Lipophilicity, and Metabolic Stability.

Journal of Medicinal Chemistry, 2016
M. Pettersson, Xinjun Hou, Max Kuhn, Travis T Wager, Gregory W. Kauffman, P. Verhoest   +5 more
semanticscholar   +1 more source

The impact of P-gp/topoisomerase I and P-gp/HER2 immunophenotypes on ovarian carcinoma features

Virchows Archiv, 2011
Szczudło, K., Nowak, P., Noga, Leszek, Rabczyński, Jerzy   +3 more
openaire  

Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers

Cellular Oncology, 2016
Yu-Lun Chen, Tsung-Ying Yang, Kun-Chieh Chen, Chieh-Liang Wu, S. Hsu, C. Hsueh   +5 more
semanticscholar   +1 more source